Standard

Solution Structure of Nucleoprotein Domain 1 from the Emerging Yezo Virus. / Gladysheva, Anastasia V.; Yanshin, Alexey O.; Radchenko, Nikita S. и др.

в: International Journal of Molecular Sciences, Том 27, № 12, 5492, 18.06.2026.

Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование

Harvard

Gladysheva, AV, Yanshin, AO, Radchenko, NS, Osinkina, IA, Ukladov, EO & Agafonov, AP 2026, 'Solution Structure of Nucleoprotein Domain 1 from the Emerging Yezo Virus', International Journal of Molecular Sciences, Том. 27, № 12, 5492. https://doi.org/10.3390/ijms27125492

APA

Gladysheva, A. V., Yanshin, A. O., Radchenko, N. S., Osinkina, I. A., Ukladov, E. O., & Agafonov, A. P. (2026). Solution Structure of Nucleoprotein Domain 1 from the Emerging Yezo Virus. International Journal of Molecular Sciences, 27(12), [5492]. https://doi.org/10.3390/ijms27125492

Vancouver

Gladysheva AV, Yanshin AO, Radchenko NS, Osinkina IA, Ukladov EO, Agafonov AP. Solution Structure of Nucleoprotein Domain 1 from the Emerging Yezo Virus. International Journal of Molecular Sciences. 2026 июнь 18;27(12):5492. doi: 10.3390/ijms27125492

Author

Gladysheva, Anastasia V. ; Yanshin, Alexey O. ; Radchenko, Nikita S. и др. / Solution Structure of Nucleoprotein Domain 1 from the Emerging Yezo Virus. в: International Journal of Molecular Sciences. 2026 ; Том 27, № 12.

BibTeX

@article{2bc02234cac54fbba087b525c4ac232a,
title = "Solution Structure of Nucleoprotein Domain 1 from the Emerging Yezo Virus",
abstract = "The Yezo virus (YEZV) is a recently discovered tick-borne orthonairovirus with pathogenic potential, causing acute febrile illness in humans. Viral nucleoproteins (N) play a key role in genome packaging, replication, and modulation of host immune responses, making their structural characterization essential for understanding viral pathogenesis and developing targeted countermeasures. However, the absence of structural data for YEZV proteins significantly hinders these efforts. This study presents the first solution structure of the YEZV N domain 1 (D1). A highly purified, soluble, tag-free recombinant YEZV N D1 was produced from the native sequence of the clinical YEZV isolate. The native-state conformation was resolved through an integrated approach combining size-exclusion chromatography coupled with small-angle X-ray scattering (SEC-SAXS), AlphaFold 3 structure prediction, and all-atom molecular dynamics simulations. The YEZV N D1 structure adopts a stable, predominantly α-helical globular fold that remains monomeric under near-physiological conditions. SEC-SAXS data show excellent agreement with computational models, revealing moderate conformational flexibility. The characterized recombinant YEZV N D1 and its first solution structure reported here providing essential insights into understanding of YEZV molecular architecture. These findings lay a foundation for rational serological assay development and structure-guided therapeutic design against this and other emerging orthonairoviruses.",
keywords = "Ixodid tick, Nairoviridae, Orthonairovirus, RNA virus, protein structure, ribonucleoprotein complex, small-angle X-ray scattering, tick-borne virus, viral protein, Иксодовый клещ, клещевой вирус, РНК-содержащий вирус, Nairoviridae, Orthonairovirus, вирусный белок, рибонуклеопротеиновый комплекс, структура белка, малоугловое рентгеновское рассеяние",
author = "Gladysheva, {Anastasia V.} and Yanshin, {Alexey O.} and Radchenko, {Nikita S.} and Osinkina, {Irina A.} and Ukladov, {Egor O.} and Agafonov, {Alexander P.}",
note = "Gladysheva, A.V.; Yanshin, A.O.; Radchenko, N.S.; Osinkina, I.A.; Ukladov, E.O.; Agafonov, A.P. Solution Structure of Nucleoprotein Domain 1 from the Emerging Yezo Virus. Int. J. Mol. Sci. 2026, 27, 5492. https://doi.org/10.3390/ijms27125492 This research was funded by The Ministry of Science and Higher Education of the Russian Federation (agreement No. 075-15-2025-452) as part of the implementation of certain activities of the Federal Scientific and Technical Program for the Development of Synchrotron and Neutron Research and Research Infrastructure.",
year = "2026",
month = jun,
day = "18",
doi = "10.3390/ijms27125492",
language = "English",
volume = "27",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "12",

}

RIS

TY - JOUR

T1 - Solution Structure of Nucleoprotein Domain 1 from the Emerging Yezo Virus

AU - Gladysheva, Anastasia V.

AU - Yanshin, Alexey O.

AU - Radchenko, Nikita S.

AU - Osinkina, Irina A.

AU - Ukladov, Egor O.

AU - Agafonov, Alexander P.

N1 - Gladysheva, A.V.; Yanshin, A.O.; Radchenko, N.S.; Osinkina, I.A.; Ukladov, E.O.; Agafonov, A.P. Solution Structure of Nucleoprotein Domain 1 from the Emerging Yezo Virus. Int. J. Mol. Sci. 2026, 27, 5492. https://doi.org/10.3390/ijms27125492 This research was funded by The Ministry of Science and Higher Education of the Russian Federation (agreement No. 075-15-2025-452) as part of the implementation of certain activities of the Federal Scientific and Technical Program for the Development of Synchrotron and Neutron Research and Research Infrastructure.

PY - 2026/6/18

Y1 - 2026/6/18

N2 - The Yezo virus (YEZV) is a recently discovered tick-borne orthonairovirus with pathogenic potential, causing acute febrile illness in humans. Viral nucleoproteins (N) play a key role in genome packaging, replication, and modulation of host immune responses, making their structural characterization essential for understanding viral pathogenesis and developing targeted countermeasures. However, the absence of structural data for YEZV proteins significantly hinders these efforts. This study presents the first solution structure of the YEZV N domain 1 (D1). A highly purified, soluble, tag-free recombinant YEZV N D1 was produced from the native sequence of the clinical YEZV isolate. The native-state conformation was resolved through an integrated approach combining size-exclusion chromatography coupled with small-angle X-ray scattering (SEC-SAXS), AlphaFold 3 structure prediction, and all-atom molecular dynamics simulations. The YEZV N D1 structure adopts a stable, predominantly α-helical globular fold that remains monomeric under near-physiological conditions. SEC-SAXS data show excellent agreement with computational models, revealing moderate conformational flexibility. The characterized recombinant YEZV N D1 and its first solution structure reported here providing essential insights into understanding of YEZV molecular architecture. These findings lay a foundation for rational serological assay development and structure-guided therapeutic design against this and other emerging orthonairoviruses.

AB - The Yezo virus (YEZV) is a recently discovered tick-borne orthonairovirus with pathogenic potential, causing acute febrile illness in humans. Viral nucleoproteins (N) play a key role in genome packaging, replication, and modulation of host immune responses, making their structural characterization essential for understanding viral pathogenesis and developing targeted countermeasures. However, the absence of structural data for YEZV proteins significantly hinders these efforts. This study presents the first solution structure of the YEZV N domain 1 (D1). A highly purified, soluble, tag-free recombinant YEZV N D1 was produced from the native sequence of the clinical YEZV isolate. The native-state conformation was resolved through an integrated approach combining size-exclusion chromatography coupled with small-angle X-ray scattering (SEC-SAXS), AlphaFold 3 structure prediction, and all-atom molecular dynamics simulations. The YEZV N D1 structure adopts a stable, predominantly α-helical globular fold that remains monomeric under near-physiological conditions. SEC-SAXS data show excellent agreement with computational models, revealing moderate conformational flexibility. The characterized recombinant YEZV N D1 and its first solution structure reported here providing essential insights into understanding of YEZV molecular architecture. These findings lay a foundation for rational serological assay development and structure-guided therapeutic design against this and other emerging orthonairoviruses.

KW - Ixodid tick

KW - Nairoviridae

KW - Orthonairovirus

KW - RNA virus

KW - protein structure

KW - ribonucleoprotein complex

KW - small-angle X-ray scattering

KW - tick-borne virus

KW - viral protein

KW - Иксодовый клещ

KW - клещевой вирус

KW - РНК-содержащий вирус

KW - Nairoviridae

KW - Orthonairovirus

KW - вирусный белок

KW - рибонуклеопротеиновый комплекс

KW - структура белка

KW - малоугловое рентгеновское рассеяние

UR - https://www.mendeley.com/catalogue/2202d4b8-6745-3846-ac48-18bcb9567ab6/

UR - https://www.scopus.com/pages/publications/105042835338

U2 - 10.3390/ijms27125492

DO - 10.3390/ijms27125492

M3 - Article

C2 - 42353207

VL - 27

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 12

M1 - 5492

ER -

ID: 85412353